The TLR-specific adjuvants R-848 and CpG-B endorse the immunological reaction of neonatal antigen-presenting cells.
about
Endothelial cells of extremely premature infants display impaired immune response after proinflammatory stimulation.Immunomodulation to Prevent or Treat Neonatal Sepsis: Past, Present, and FutureModified FeO Magnetic Nanoparticle Delivery of CpG Inhibits Tumor Growth and Spontaneous Pulmonary Metastases to Enhance Immunotherapy
P2860
The TLR-specific adjuvants R-848 and CpG-B endorse the immunological reaction of neonatal antigen-presenting cells.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
The TLR-specific adjuvants R-8 ...... atal antigen-presenting cells.
@en
The TLR-specific adjuvants R-8 ...... atal antigen-presenting cells.
@nl
type
label
The TLR-specific adjuvants R-8 ...... atal antigen-presenting cells.
@en
The TLR-specific adjuvants R-8 ...... atal antigen-presenting cells.
@nl
prefLabel
The TLR-specific adjuvants R-8 ...... atal antigen-presenting cells.
@en
The TLR-specific adjuvants R-8 ...... atal antigen-presenting cells.
@nl
P2093
P2860
P50
P356
P1433
P1476
The TLR-specific adjuvants R-8 ...... atal antigen-presenting cells.
@en
P2093
Erich Gindl
Hanns Helmer
Peter Husslein
Simone Schüller
P2860
P2888
P304
P356
10.1038/PR.2016.71
P407
P577
2016-04-08T00:00:00Z
P6179
1033739435